Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice

Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression

(2018) Hayley Coffing et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection

(2018) Shinsmon Jose et al.   ANAEROBE

Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites

(2018) Jiani Wang et al.   GASTROENTEROLOGY

SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis

(2018) Xiangming Ding et al.   LABORATORY INVESTIGATION

Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis

(2018) Pedro H. V. Saavedra et al.   Nature Communications

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

(2017) Mark H. Wilcox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model

(2017) Yi-Wen Liu et al.   Frontiers in Microbiology

Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters

(2016) Hon Wai Koon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections

(2016) Shinsmon Jose et al.   ANAEROBE

The molecular basis of Clostridium difficile disease and host response

(2015) Rana E. El Feghaly et al.   CURRENT OPINION IN GASTROENTEROLOGY

Clostridium Difficile Infection from a Surgical Perspective

(2015) Andreas M. Kaiser et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum

(2014) Hon Wai Koon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis

(2014) Shan Li et al.   INFECTION AND IMMUNITY

Slc26a3 deficiency is associated with loss of colonic HCO3−secretion, absence of a firm mucus layer and barrier impairment in mice

(2013) F. Xiao et al.   Acta Physiologica

Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections

(2013) Christina M Surawicz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes

(2013) Hon Wai Koon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of Interleukin 23 Signaling in Clostridium difficile Colitis

(2013) Erica L. Buonomo et al.   JOURNAL OF INFECTIOUS DISEASES

Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice

(2012) C. A. Warren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The antimicrobial peptide cathelicidin modulatesClostridium difficile-associated colitis and toxin A-mediated enteritis in mice

(2012) Tressia C Hing et al.   GUT

Autocrine Regulation of Re-Epithelialization After Wounding by Chemokine Receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3

(2011) Kim L. Kroeze et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Clostridium difficile Toxin–Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome

(2010) Jeffrey Ng et al.   GASTROENTEROLOGY